Selank in Jiuhe — Anxiolytic Peptide Research Guide
Selank peptide guide for Jiuhe. Covers anxiolytic mechanisms, purity standards, COA verification, nasal administration, and how to source quality Selank for research.
For anyone in Jiuhe trying to locate Selank, the first thing to know is that this compound is available only through an online research supply market. What this means for Jiuhe researchers is that geography is secondary to your ability to assess COA data — and those verification methods are accessible to anyone. Separating properly characterised Selank from the rest of the market comes down to three things: an HPLC chromatogram documenting ≥98% purity, mass spec data verifying the correct molecular weight, and a batch-specific endotoxin panel. The sections below cover what Jiuhe researchers need to know about purchasing, testing, and working with Selank for scientific research use.
How Selank Works — Mechanisms & Research
The cognitive peptide research area overlaps significantly with stress biology, given that many neuropeptides have dual roles in both cognitive and stress response pathways. Selank's activity on the GABAergic system produces anxiolytic effects alongside nootropic effects, and this co-activity is relevant to research design — cognitive outcome measures in high-anxiety model animals may reflect anxiolysis as much as direct cognitive enhancement from Selank. Separating these effects requires protocol designs that include stress-reduced control conditions. For Jiuhe researchers in cognitive neuroscience, this mechanistic complexity is an opportunity for nuanced research design rather than a limitation.
Sourcing Research-Grade Selank
Before assessing any particular supplier, understand what genuine quality documentation contains — so you can recognise whether a vendor meets it. Endotoxin testing in the COA is non-negotiable for any injectable research use — endotoxins from bacterial cell wall components can trigger dangerous inflammatory cascades even at very low concentrations. Strong quality indicators beyond COA quality: established track record of at least two years, customer service that can discuss analytical methods, and cold chain packaging that protects product integrity. Hold lyophilised Selank at minus 20 degrees Celsius until ready to use; reconstitute only the volume needed for upcoming use and keep the remainder frozen.
Order Selank — ships to Jiuhe
COA-verified · International tracking · Research grade
Selank is supplied strictly for research applications and is not approved for human therapeutic use by the FDA or comparable health authorities — all information here is for educational purposes only. Reconstitute Selank with bacteriostatic water at an appropriate concentration for your protocol; a standard 5mg in 2mL gives a 2.5mg/mL solution — or 25mcg per insulin syringe unit. The most significant preventable safety hazard in Selank research is endotoxin contamination from poor sourcing — a documented endotoxin result in your specific batch certificate is the specific protection against this risk. Researchers combining Selank with other compounds should review the available literature for documented interactions before running stacked compound experiments.
Frequently Asked Questions
Is Selank similar to Semax?
Semax and Selank are both synthetic neuropeptides developed by the same Russian institution with overlapping clinical applications. They have distinct mechanisms: Semax primarily upregulates BDNF and acts on ACTH receptor systems; Selank primarily modulates GABAergic transmission and enkephalin activity. They are sometimes studied in combination.
What is Selank?
Selank is a synthetic analogue of tuftsin (a tetrapeptide fragment of immunoglobulin G) with three additional amino acids for stability. It has been studied for anxiolytic effects, cognitive enhancement, and GABAergic system modulation. Like Semax, it was developed by the Institute of Molecular Genetics in Russia and has a clinical history in Russian medicine.
What is the administration route for Selank research?
Like Semax, Selank is primarily studied via intranasal administration for CNS applications, utilizing olfactory nerve transport to bypass the blood-brain barrier. The solution concentration used in research is typically 0.15% (1.5mg/mL). Subcutaneous administration has also been studied in animal models.
How does Selank produce anxiolytic effects?
Selank's anxiolytic mechanism is thought to involve modulation of GABAergic transmission (similar but distinct to benzodiazepines), inhibition of enkephalinase (extending the activity of endogenous enkephalins), and BDNF expression modulation. The multi-mechanism profile distinguishes it from single-target anxiolytics.
